Publication: Selective inhibition of plasma membrane calcium ATPase 4 improves angiogenesis and vascular reperfusion
dc.contributor.author | Kurusamy, Sathishkumar | |
dc.contributor.author | Lopez-Maderuelo, Dolores | |
dc.contributor.author | Little, Robert | |
dc.contributor.author | Cadagan, David | |
dc.contributor.author | Savage, Aaron M | |
dc.contributor.author | Ihugba, Jude C | |
dc.contributor.author | Baggott, Rhiannon R | |
dc.contributor.author | Rowther, Farjana B | |
dc.contributor.author | Martinez-Martinez, Sara | |
dc.contributor.author | Gomez-del Arco, Pablo | |
dc.contributor.author | Murcott, Clare | |
dc.contributor.author | Wang, Weiguang | |
dc.contributor.author | Francisco Nistal, J | |
dc.contributor.author | Oceandy, Delvac | |
dc.contributor.author | Neyses, Ludwig | |
dc.contributor.author | Wilkinson, Robert N | |
dc.contributor.author | Cartwright, Elizabeth J | |
dc.contributor.author | Redondo, Juan Miguel | |
dc.contributor.author | Armesilla, Angel Luis | |
dc.contributor.funder | Ministerio de EconomÃa, Industria y Competitividad (España) | |
dc.contributor.funder | Ministerio de Sanidad y PolÃtica Social (España) | |
dc.contributor.funder | Centro de Investigación Biomedica en Red - CIBER | |
dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | |
dc.contributor.funder | Fundación La Marató TV3 | |
dc.contributor.funder | Fundación ProCNIC | |
dc.date.accessioned | 2020-04-30T14:00:57Z | |
dc.date.available | 2020-04-30T14:00:57Z | |
dc.date.issued | 2017-08 | |
dc.description.abstract | AIMS: Ischaemic cardiovascular disease is a major cause of morbidity and mortality worldwide. Despite promising results from pre-clinical animal models, VEGF-based strategies for therapeutic angiogenesis have yet to achieve successful reperfusion of ischaemic tissues in patients. Failure to restore efficient VEGF activity in the ischaemic organ remains a major problem in current pro-angiogenic therapeutic approaches. Plasma membrane calcium ATPase 4 (PMCA4) negatively regulates VEGF-activated angiogenesis via inhibition of the calcineurin/NFAT signalling pathway. PMCA4 activity is inhibited by the small molecule aurintricarboxylic acid (ATA). We hypothesize that inhibition of PMCA4 with ATA might enhance VEGF-induced angiogenesis. METHODS AND RESULTS: We show that inhibition of PMCA4 with ATA in endothelial cells triggers a marked increase in VEGF-activated calcineurin/NFAT signalling that translates into a strong increase in endothelial cell motility and blood vessel formation. ATA enhances VEGF-induced calcineurin signalling by disrupting the interaction between PMCA4 and calcineurin at the endothelial-cell membrane. ATA concentrations at the nanomolar range, that efficiently inhibit PMCA4, had no deleterious effect on endothelial-cell viability or zebrafish embryonic development. However, high ATA concentrations at the micromolar level impaired endothelial cell viability and tubular morphogenesis, and were associated with toxicity in zebrafish embryos. In mice undergoing experimentally-induced hindlimb ischaemia, ATA treatment significantly increased the reperfusion of post-ischaemic limbs. CONCLUSIONS: Our study provides evidence for the therapeutic potential of targeting PMCA4 to improve VEGF-based pro-angiogenic interventions. This goal will require the development of refined, highly selective versions of ATA, or the identification of novel PMCA4 inhibitors. | es_ES |
dc.description.peerreviewed | SÃ | es_ES |
dc.description.sponsorship | This work was supported by the Research Institute in Healthcare Sciences, Faculty of Science and Engineering, University of Wolverhampton (to A.L.A.), and by an MRC programme grant (grant G1002082 to L.N. and E.J.C.). J.M.R. is supported by the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) (grant SAF2015-636333 to J.M.R.) and CIBERCV of Ministerio de Sanidad (grant CB16/11/00264 to J.M.R.), all projects cofounded by FEDER. J.M.R. and J.F.N. are supported by Red de Investigacion Cardiovascular (RD12/0042/0018 and 0022) cofounded by FEDER. S.K. and A.L.A. are supported by the Rosetrees Trust (grant M531 to A.L.A). S.M-M. and J.M.R. are supported by grants from the Fundacion La Marato TV3 (grant 20122532 to S.M-M. and grant 20151331 to J.M.R.). The Centro Nacional de Investigaciones Cardiovasculares (CNIC) is supported by the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (Award SEV-2015-0505). | es_ES |
dc.format.page | 38-47 | es_ES |
dc.format.volume | 109 | es_ES |
dc.identifier.citation | J Mol Cell Cardiol. 2017; 109:38-47 | es_ES |
dc.identifier.doi | 10.1016/j.yjmcc.2017.07.001 | es_ES |
dc.identifier.e-issn | 1095-8584 | es_ES |
dc.identifier.issn | 0022-2828 | es_ES |
dc.identifier.journal | Journal of molecular and cellular cardiology | es_ES |
dc.identifier.pubmedID | 28684310 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/9848 | |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/SEV-2015-0505 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/SAF2015-636333 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/CB16/11/00264 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/RD12/0042/0018 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/RD12/0042/0022 | es_ES |
dc.relation.publisherversion | https://doi.org/10.1016/j.yjmcc.2017.07.001 | es_ES |
dc.repisalud.institucion | CNIC | es_ES |
dc.repisalud.orgCNIC | CNIC::Grupos de investigación::Regulación Génica en Remodelado Vascular e Inflamación | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | ATA | es_ES |
dc.subject | Angiogenesis | es_ES |
dc.subject | Calcineurin/NFAT | es_ES |
dc.subject | PMCA4 | es_ES |
dc.subject | VEGF | es_ES |
dc.subject.mesh | Animals | es_ES |
dc.subject.mesh | Aurintricarboxylic Acid | es_ES |
dc.subject.mesh | Calcium-Transporting ATPases | es_ES |
dc.subject.mesh | Cell Membrane | es_ES |
dc.subject.mesh | Cell Movement | es_ES |
dc.subject.mesh | Human Umbilical Vein Endothelial Cells | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Mice | es_ES |
dc.subject.mesh | Mice, Knockout | es_ES |
dc.subject.mesh | Neovascularization, Physiologic | es_ES |
dc.subject.mesh | Zebrafish | es_ES |
dc.subject.mesh | Zebrafish Proteins | es_ES |
dc.title | Selective inhibition of plasma membrane calcium ATPase 4 improves angiogenesis and vascular reperfusion | es_ES |
dc.type | journal article | es_ES |
dc.type.hasVersion | AM | es_ES |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 4b59ac48-1490-4b7f-a4e3-e38574bc9990 | |
relation.isAuthorOfPublication | 54f24aa4-8adb-40fd-a254-c3584f013b76 | |
relation.isAuthorOfPublication | 58e362fa-54ae-42f3-a7f5-d28d7229122c | |
relation.isAuthorOfPublication | 9feed430-9a0d-4597-82cd-71cec263d8fe | |
relation.isAuthorOfPublication.latestForDiscovery | 4b59ac48-1490-4b7f-a4e3-e38574bc9990 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- SelectiveInhibitionPlasmaMembrane_2017.pdf
- Size:
- 15.4 MB
- Format:
- Adobe Portable Document Format
- Description: